Position in RVTY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,056,084
+$429,605 QoQ
Shares Held
18,480
-0.5% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#159
of 538 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RVTY Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MAI Capital Management holds $75,211,966 across 16 Diagnostics & Research names. RVTY ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
71,216 | $35,704,853 | |
| 2 | LH |
Labcorp Holdings Inc.
|
35,684 | $9,991,520 | |
| 3 | DHR |
Danaher Corp /De/
|
42,750 | $8,143,019 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
32,244 | $6,230,184 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
1,721 | $2,198,594 | |
| 6 | RVTY |
Revvity, Inc.
This page
|
18,480 | $2,056,084 | |
| 7 | WAT |
Waters Corp /De/
|
5,287 | $1,982,836 | |
| 8 | A |
Agilent Technologies, Inc.
|
14,111 | $1,874,363 |
All Filings in RVTY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,056,084 | 18,480 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,626,479 | 18,565 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,806,225 | 18,669 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,673,676 | 19,095 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,919,505 | 19,846 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,176,094 | 20,568 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,334,881 | 20,920 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||